THE AMPK-ON™ PLATFORM
Three benefits.
Three benefits.
One biology.
Actiponin® is supported by human clinical research across body-fat, cholesterol, and joint-health endpoints.
01
METABOLIC
Body Fat
−1.25 kg
Cholesterol
−9.69 mg/dL
Joint
−8.7
Body Fat
Reduction
−1.25 kg
Body fat mass · 12-week RCT · n = 80
VIEW CLINICAL EVIDENCE → 02 CARDIOVASCULARCholesterol
Reduction
−9.69 mg/dL
Total cholesterol · company brochure summary
VIEW CLINICAL EVIDENCE → 03 JOINT & MOBILITYJoint
Health
−8.7
WOMAC change · 450 mg/day · n = 50/group
VIEW CLINICAL EVIDENCE →
HUMAN CLINICAL EVIDENCE
3 studies290 participants12 weeks each
Study figures and counts are cited from supplied company materials. Individual results and regulatory claims depend on the study, formulation and market. Full clinical reports are available on request.
SIGNATURE COMPOUNDS
VIEW ANALYSIS →
Damulin A
Damulin BAMPK SCIENCE
EXPLORE AMPK SCIENCE →
EVIDENCE & DOCUMENTS
EVIDENCE & DOCUMENTS